23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.36%
Revenue growth exceeding 1.5x Insurance - Life median of 2.10%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
18.36%
Gross profit growth exceeding 1.5x Insurance - Life median of 2.10%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
14.65%
Positive EBIT growth while Insurance - Life median is negative. Peter Lynch might see a strong competitive advantage in operations.
14.65%
Operating income growth of 14.65% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
13.00%
Net income growth 1.25-1.5x Insurance - Life median of 11.38%. Mohnish Pabrai would confirm consistent strategy or niche leadership behind these results.
12.91%
EPS growth of 12.91% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
12.88%
Diluted EPS growth of 12.88% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10403.43%
Negative OCF growth while Insurance - Life median is -40.79%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-10403.43%
Negative FCF growth while Insurance - Life median is -40.17%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
18.17%
10Y revenue/share CAGR below 50% of Insurance - Life median of 68.22%. Jim Chanos would suspect deep structural or market share issues.
18.17%
Below 50% of Insurance - Life median. Jim Chanos would suspect structural disadvantages or a higher share base limiting per-share growth.
18.17%
3Y revenue/share growth 75-90% of Insurance - Life median of 23.13%. John Neff would see if operational improvements can catch up with peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.81%
Net income/share CAGR near Insurance - Life median. Charlie Munger might see typical industry-level profit expansion over 10 years.
53.81%
5Y net income/share CAGR near Insurance - Life median. Charlie Munger might see standard mid-cycle performance in a healthy sector.
53.81%
3Y net income/share CAGR near Insurance - Life median. Charlie Munger sees standard sector-level performance in the last few years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.94%
Asset growth exceeding 1.5x Insurance - Life median of 0.26%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
21.45%
BV/share growth of 21.45% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-1.24%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.